FDLI CEO has device background
Executive Summary
Food & Drug Law Institute names former Carl Zeiss CEO James Kelly president and CEO effective Aug. 14. Prior to working at Zeiss, Kelly held various positions with Siemens Medical, including head of human resources. Kelly's device background contrasts with his predecessor Jerome Halperin, who headed U.S. Pharmacopeia prior to joining FDLI nearly five years ago (1"The Pink Sheet" April 2, 2001, p. 36)...